- Home
- AGIO vs VSCO Comparison
AGIO vs VSCO Comparison
Compare AGIO & VSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- VSCO
- Stock Information
- Founded
- AGIO 2007
- VSCO 1977
- Country
- AGIO United States
- VSCO United States
- Employees
- AGIO N/A
- VSCO N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- VSCO Clothing/Shoe/Accessory Stores
- Sector
- AGIO Health Care
- VSCO Consumer Discretionary
- Exchange
- AGIO Nasdaq
- VSCO Nasdaq
- Market Cap
- AGIO 2.4B
- VSCO 2.1B
- IPO Year
- AGIO 2013
- VSCO N/A
- Fundamental
- Price
- AGIO $43.18
- VSCO $33.87
- Analyst Decision
- AGIO Strong Buy
- VSCO Hold
- Analyst Count
- AGIO 4
- VSCO 12
- Target Price
- AGIO $59.33
- VSCO $29.50
- AVG Volume (30 Days)
- AGIO 514.0K
- VSCO 2.1M
- Earning Date
- AGIO 10-30-2025
- VSCO 12-04-2025
- Dividend Yield
- AGIO N/A
- VSCO N/A
- EPS Growth
- AGIO N/A
- VSCO 6.76
- EPS
- AGIO 11.13
- VSCO 1.86
- Revenue
- AGIO $40,875,000.00
- VSCO $6,265,000,000.00
- Revenue This Year
- AGIO $23.74
- VSCO $4.70
- Revenue Next Year
- AGIO $159.90
- VSCO $2.67
- P/E Ratio
- AGIO $3.77
- VSCO $19.52
- Revenue Growth
- AGIO 30.57
- VSCO 2.29
- 52 Week Low
- AGIO $23.42
- VSCO $13.76
- 52 Week High
- AGIO $62.58
- VSCO $48.73
- Technical
- Relative Strength Index (RSI)
- AGIO 50.11
- VSCO 70.59
- Support Level
- AGIO $41.24
- VSCO $30.65
- Resistance Level
- AGIO $44.25
- VSCO $38.05
- Average True Range (ATR)
- AGIO 1.52
- VSCO 1.37
- MACD
- AGIO -0.16
- VSCO 0.36
- Stochastic Oscillator
- AGIO 31.28
- VSCO 69.39
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.